Stock To Watch: Abbott Laboratories (NYSE:ABT)


The leading market experts have placed a mean price target of $46.73 on Abbott Laboratories (NYSE:ABT) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.59 a share for the upcoming quarter and $2.21 for the current fiscal. Technical View The technical analysis of Abbott Laboratories Common Stoc plainly substantiates that the 50-day moving average of Abbott Laboratories Common Stoc is $38.38, and stock is hovering -0.99 or -2.58% distant from $38.38. It is noted that the 200-day MA is $40.69, and Abbott Laboratories Common Stoc stock is $-3.30 or -8.11% off from this point. Abbott Laboratories (NYSE:ABT) 52-week high is $51.74 and the 52-week low is $36.00. This explains if the stock moves $-14.35, it will post a 52-week high. In event of $+3.86% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Abbott Laboratories Common Stoc, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Abbott Laboratories (NYSE:ABT) ratio came in at 23.02. The stock last ended the trading session at $37.39 and registered a market cap of $54.93B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Abbott Laboratories (NYSE:ABT) PEG ratio is at 1.80.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 4 times, 1 visits today)